Back to results
US 9,956,234 B2Granted
Osteoclast inhibitors for joint conditions
AssigneeAntecip Bioventures II LLC
InventorHerriot Tabuteau
Life of this patent
Estimating the term…
Abstract
Oral dosage forms of osteoclast inhibitors, such as neridronic acid and zoledronic acid, in an acid or a salt form can be used to treat or alleviate pain or related conditions, such as joint pain.
Claims30
A method of treating pain associated with a hip joint comprising:
- a. selecting a patient having 1) pain associated with a hip joint and 2) a pain intensity of 5 or greater measured using the 0-10 numerical rating scale (NRS) or 5 cm or greater using the 10 cm visual analogue scale (VAS);
- and
- b. administering neridronic acid to the patient.
A method of treating pain associated with a hip joint comprising:
- a. selecting a patient having 1) pain associated with a hip joint and 2) a pain intensity of 5 or greater measured using the 0-10 NRS or 5 cm or greater using the 10 cm VAS;
- and
- b. orally administering neridronic acid to the patient.
Dependencies are inferred from the claim text.